Psilocybin, the key psychoactive compound in magic mushrooms, continues to be a federally-managed Program I drug; that means that psilocybin mushrooms are thought of to obtain no medically acknowledged use and carry a superior opportunity for abuse. But FDA-authorised trials for the selected breakthrough therapy continue following scientific tests